In this issue:
Baricitinib for SLE
Early infection risk in SLE treated with rituximab or belimumab
B-cell-targeted therapies in SLE
Global epidemiology of SLE
Threshold score for SLE
Deucravacitinib use in SLE
CNS involvement in SLE
Children’s exposure to hydroxychloroquine or azathioprine
Rituximab following remission in SLE
Hydroxychloroquine use and CV events in SLE
Please login below to download this issue (PDF)